| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2008 | US20080009548 Ambroxol for the treatment of acute pain |
| 01/10/2008 | US20080009547 Method for inhibiting or reversing non-enzymatic glycation |
| 01/10/2008 | US20080009546 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders |
| 01/10/2008 | US20080009545 Anticancer agents |
| 01/10/2008 | US20080009544 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors |
| 01/10/2008 | US20080009543 N-[[4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-thienyl]methyl]-2-propylpentanamide; cannabinoid CB1 receptor antagonists; drug abuse, drug dependency; psychological disorders; antidepressants; antiepileptic agents; cogntion activators; analgesics; eating disorders |
| 01/10/2008 | US20080009542 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |
| 01/10/2008 | US20080009541 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration |
| 01/10/2008 | US20080009540 Amorphous Atorvastatin Calcium |
| 01/10/2008 | US20080009539 Azo Compounds and Process for Production Thereof |
| 01/10/2008 | US20080009538 Methods and compositions for the treatment of urinary incontinence |
| 01/10/2008 | US20080009537 Therapeutic Agent for Diabetes Comprising Protease-Inhibiting Compound |
| 01/10/2008 | US20080009536 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 01/10/2008 | US20080009535 Inhibitors of phosphodiesterase type-IV |
| 01/10/2008 | US20080009534 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | US20080009533 Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, used for treating atherosclerosis, dyslipidemia, diabetes, non-insulin dependent diabetes, hyperglycemia, hyperinsulinemia and obesity |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009530 Therapeutic Agent for Diabetes |
| 01/10/2008 | US20080009528 such as 4-(2,4-dichlorophenyl)-6-(3-hydroxyphenyl)-2-methyl-3-cyanopyridine, used for inhibiting growth of Gram-positive bacteria selected from Bacillus, Listeria, Staphylococcus, Streptococcus, Enterococcus, Corynebacterium, Propionibacterium and Clostridium |
| 01/10/2008 | US20080009527 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009523 New Pyridine Analogues IV |
| 01/10/2008 | US20080009522 Biphenylcarboxamides useful as lipid lowering agents |
| 01/10/2008 | US20080009521 Aryl Piperidine Amides |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009519 Method of modulating t cell functioning |
| 01/10/2008 | US20080009518 5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists |
| 01/10/2008 | US20080009517 Use of nelfinavir as a radiation sensitizer |
| 01/10/2008 | US20080009516 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 01/10/2008 | US20080009515 Substituted thieno[3,2-C]pyridine carboxylic acid derivatives |
| 01/10/2008 | US20080009514 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | US20080009513 Therapeutic agents |
| 01/10/2008 | US20080009512 Tetrahydroquinolones and Aza-Analogues Thereof for Use as Dpp-IV Inhibitors in the Treatment of Diabetes |
| 01/10/2008 | US20080009511 Cancer treatment with compounds inhibiting PKC alpha |
| 01/10/2008 | US20080009510 Fused Aminopiperidine as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/10/2008 | US20080009509 Quinazoline Derivatives For Inhibiting Cancer Cell Growth And Method For The Preparation Thereof |
| 01/10/2008 | US20080009508 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin |
| 01/10/2008 | US20080009507 Cancer; such as 2-[4-(1-amino-1-methylethyl)phenyl]-3-(2-thienyl)-1,6-naphthyridin-5(6H)-one; serine/threonine kinase (Akt) suppression |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009505 Theanine derivatives, uses thereof and processes for the manufacture thereof |
| 01/10/2008 | US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid |
| 01/10/2008 | US20080009503 Method of treating diabetes |
| 01/10/2008 | US20080009502 Tadalafil solid composites |
| 01/10/2008 | US20080009501 Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 01/10/2008 | US20080009500 Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders |
| 01/10/2008 | US20080009499 3-(2,2-Dimethyl-propyl)-5,6,7,8,9,10-hexahydro-cycloocta[c]pyridazine; 11beta-hydroxysteroid dehydrogenase (11b-HSD1) inhibitors; diabetes, obesity, eating disorders, dyslipidemiae and hypertension |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/10/2008 | US20080009497 Pyrrolotriazine kinase inhibitors |
| 01/10/2008 | US20080009496 Mutagenic heterocycles |
| 01/10/2008 | US20080009495 Compound Containing Basic Group and Use Thereof |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009492 (2-Phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-carbamic acid isopropyl ester, used in the control or prevention of illnesses such as cancer; anticarcinogenic agents |
| 01/10/2008 | US20080009491 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080009489 Androgen receptor modulators and method of treating disease using the same |
| 01/10/2008 | US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion |
| 01/10/2008 | US20080009487 Treatment of athersclerotic disease |
| 01/10/2008 | US20080009486 6-chloro-2'-(3-chlorophenyl)-4'-(2,2-dimethylpropyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione; mdm2 antagonists; have effects in p53 mutant cells by mdm2-p53 feedback control loop; anticarcinogenic agent; |
| 01/10/2008 | US20080009485 Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis |
| 01/10/2008 | US20080009484 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/10/2008 | US20080009483 3-{[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]methyl}-N-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-4-hydroxycyclopentanecarboxamide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/10/2008 | US20080009482 Novel compounds |
| 01/10/2008 | US20080009481 Process For Making Form I Of Olanzapine |
| 01/10/2008 | US20080009480 CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
| 01/10/2008 | US20080009479 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands |
| 01/10/2008 | US20080009478 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| 01/10/2008 | US20080009477 Arylalkyl Ureas As Cb1 Antagonists |
| 01/10/2008 | US20080009476 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 01/10/2008 | US20080009475 Pharmacological treatment of cognitive impairment |
| 01/10/2008 | US20080009474 of sulopenem, comprising (2-ethyl-1-oxobutoxy)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicydo[3.2.0]hept-2-ene-2-carboxylate, used to treat and prevent bacterial infection in humans; antibiotics |
| 01/10/2008 | US20080009473 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 01/10/2008 | US20080009472 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/10/2008 | US20080009471 Ocular delivery of triamcinolone acetonide phosphate and related compounds |
| 01/10/2008 | US20080009470 Acremonic Acid Derivatives |
| 01/10/2008 | US20080009469 Medicament for Threapeutic Treating of Pain |
| 01/10/2008 | US20080009468 Method for reducing psa levels |
| 01/10/2008 | US20080009467 Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| 01/10/2008 | US20080009466 Crystalline forms of ibandronic acid and processes for preparation thereof |
| 01/10/2008 | US20080009465 Novel glucokinase activators and methods of using same |
| 01/10/2008 | US20080009464 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/10/2008 | US20080009461 Therapeutic compounds |
| 01/10/2008 | US20080009460 Method to treat sickle cell disease |
| 01/10/2008 | US20080009459 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009454 Polynucleotide |
| 01/10/2008 | US20080009453 Pharmceutical Compositions Containing Polydatin or Its Salts and Their Application |
| 01/10/2008 | US20080009451 Applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor |
| 01/10/2008 | US20080009450 Genipin derivatives and uses thereof |
| 01/10/2008 | US20080009449 Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis |
| 01/10/2008 | US20080009447 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal |
| 01/10/2008 | US20080009445 Anti-endotoxic, antimicrobial cationic peptides, the encoding DNA and methods of use thereof |
| 01/10/2008 | US20080009437 Pharmaceutical Compositions and Method for Treating Dry Eye |
| 01/10/2008 | US20080008773 Food beverage or feed for the promotion of osteogenesis comprising umbelliferae, liliaceae or compositae plant species |
| 01/10/2008 | US20080008772 Narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 01/10/2008 | US20080008771 Nitric Oxide Dioxygenase Inhibitors |
| 01/10/2008 | US20080008769 Treatment of urinary tract infections |